Filed: 5/15/2023ACC: 0001104659-23-060173
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $135.74M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$135.74M
Total AUM (reported)
8.81M
Total Shares
Allocation by class
COM$114.55M84.4%
COM NEW$14.12M10.4%
SPONSORED ADR$3.57M2.6%
ORDINARY SHARES$1.94M1.4%
SHS$1.55M1.1%
*W EXP 07/07/2027$10.9K0.0%
Portfolio Concentration
Top 3$45.57M33.6%
4–10$45.72M33.7%
11–25$41.25M30.4%
Rest$3.21M2.4%
Top 3 weight
33.6%
Top 10 weight
67.3%
Voting Authority Distribution
Total shares with voting rights: 8.81M
Sole
Full voting authority
8.81M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares290.50K
TypeSH
Market value$19.16M
14.12%
Sole
290.50K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
SOLEShares1.85M
TypeSH
Market value$13.39M
9.86%
Sole
1.85M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares1.10M
TypeSH
Market value$13.02M
9.59%
Sole
1.10M
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC. COMMON STOCK
SOLEShares878.50K
TypeSH
Market value$7.66M
5.64%
Sole
878.50K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares208.50K
TypeSH
Market value$6.98M
5.15%
Sole
208.50K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares330K
TypeSH
Market value$6.97M
5.13%
Sole
330K
Shared
0.00
None
0.00
KURA ONCOLOGY INC. COMMON STOCK
SOLEShares565.26K
TypeSH
Market value$6.91M
5.09%
Sole
565.26K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares280.50K
TypeSH
Market value$6.82M
5.03%
Sole
280.50K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares23.50K
TypeSH
Market value$5.26M
3.88%
Sole
23.50K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares298K
TypeSH
Market value$5.10M
3.76%
Sole
298K
Shared
0.00
None
0.00
BELLUS HEALTH INC
SOLEShares632.50K
TypeSH
Market value$4.55M
3.35%
Sole
632.50K
Shared
0.00
None
0.00
SAREPTA TEHRAPEUTICS INC
SOLEShares32.77K
TypeSH
Market value$4.52M
3.33%
Sole
32.77K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares120.50K
TypeSH
Market value$4.52M
3.33%
Sole
120.50K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares121.50K
TypeSH
Market value$4.37M
3.22%
Sole
121.50K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares168K
TypeSH
Market value$4.27M
3.15%
Sole
168K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares1.50K
TypeSH
Market value$3.65M
2.69%
Sole
1.50K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares1K
TypeSH
Market value$3.60M
2.65%
Sole
1K
Shared
0.00
None
0.00
ARGEN SE
SOLEShares9.59K
TypeSH
Market value$3.57M
2.63%
Sole
9.59K
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares243.25K
TypeSH
Market value$1.94M
1.43%
Sole
243.25K
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS INC
SOLEShares104.75K
TypeSH
Market value$1.80M
1.33%
Sole
104.75K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS
SOLEShares121.84K
TypeSH
Market value$985.7K
0.73%
Sole
121.84K
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares153.64K
TypeSH
Market value$938.7K
0.69%
Sole
153.64K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares31.69K
TypeSH
Market value$893.3K
0.66%
Sole
31.69K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares303.40K
TypeSH
Market value$892.0K
0.66%
Sole
303.40K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares154.47K
TypeSH
Market value$736.8K
0.54%
Sole
154.47K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 290.50K | SH | $19.16M 14.12% | 290.50K | 0.00 | 0.00 |
AADI BIOSCIENCES INCSOLE | COM | 1.85M | SH | $13.39M 9.86% | 1.85M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 1.10M | SH | $13.02M 9.59% | 1.10M | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INC. COMMON STOCKSOLE | COM | 878.50K | SH | $7.66M 5.64% | 878.50K | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 208.50K | SH | $6.98M 5.15% | 208.50K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 330K | SH | $6.97M 5.13% | 330K | 0.00 | 0.00 |
KURA ONCOLOGY INC. COMMON STOCKSOLE | COM | 565.26K | SH | $6.91M 5.09% | 565.26K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 280.50K | SH | $6.82M 5.03% | 280.50K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 23.50K | SH | $5.26M 3.88% | 23.50K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 298K | SH | $5.10M 3.76% | 298K | 0.00 | 0.00 |
BELLUS HEALTH INCSOLE | COM NEW | 632.50K | SH | $4.55M 3.35% | 632.50K | 0.00 | 0.00 |
SAREPTA TEHRAPEUTICS INCSOLE | COM | 32.77K | SH | $4.52M 3.33% | 32.77K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 120.50K | SH | $4.52M 3.33% | 120.50K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 121.50K | SH | $4.37M 3.22% | 121.50K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 168K | SH | $4.27M 3.15% | 168K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 1.50K | SH | $3.65M 2.69% | 1.50K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 1K | SH | $3.60M 2.65% | 1K | 0.00 | 0.00 |
ARGEN SESOLE | SPONSORED ADR | 9.59K | SH | $3.57M 2.63% | 9.59K | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 243.25K | SH | $1.94M 1.43% | 243.25K | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INCSOLE | COM | 104.75K | SH | $1.80M 1.33% | 104.75K | 0.00 | 0.00 |
ACLARIS THERAPEUTICSSOLE | COM | 121.84K | SH | $985.7K 0.73% | 121.84K | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 153.64K | SH | $938.7K 0.69% | 153.64K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 31.69K | SH | $893.3K 0.66% | 31.69K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 303.40K | SH | $892.0K 0.66% | 303.40K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 154.47K | SH | $736.8K 0.54% | 154.47K | 0.00 | 0.00 |
Page 1 of 2